ProQR Therapeutics (PRQR) Total Current Liabilities (2021 - 2024)
Historic Total Current Liabilities for ProQR Therapeutics (PRQR) over the last 4 years, with Q4 2024 value amounting to $41.6 million.
- ProQR Therapeutics' Total Current Liabilities rose 1296.22% to $41.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $41.6 million, marking a year-over-year increase of 1296.22%. This contributed to the annual value of $42.1 million for FY2024, which is 1380.38% up from last year.
- As of Q4 2024, ProQR Therapeutics' Total Current Liabilities stood at $41.6 million, which was up 1296.22% from $36.8 million recorded in Q4 2023.
- In the past 5 years, ProQR Therapeutics' Total Current Liabilities ranged from a high of $41.6 million in Q4 2024 and a low of $12658.2 during Q1 2021
- Moreover, its 4-year median value for Total Current Liabilities was $27.2 million (2022), whereas its average is $26.3 million.
- Data for ProQR Therapeutics' Total Current Liabilities shows a peak YoY increase of 21016805.7% (in 2022) and a maximum YoY decrease of 3351.97% (in 2022) over the last 5 years.
- ProQR Therapeutics' Total Current Liabilities (Quarter) stood at $31.6 million in 2021, then crashed by 32.17% to $21.4 million in 2022, then surged by 71.86% to $36.8 million in 2023, then rose by 12.96% to $41.6 million in 2024.
- Its Total Current Liabilities was $41.6 million in Q4 2024, compared to $36.8 million in Q4 2023 and $29.0 million in Q3 2023.